Viridian Therapeutics
VRDN
VRDN
11 hedge funds and large institutions have $1.32M invested in Viridian Therapeutics in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and closing their positions.
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PCM
1
Perkins Capital Management
Wayzata,
Minnesota
| $449K | 209,000 | +159,200 | +320% |
|
|
HA
2
Heartland Advisors
Milwaukee,
Wisconsin
| $430K | 200,000 | +8,300 | +4% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $166K | 77,086 | +77,086 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $104K | 48,600 | +48,600 | New |
|
|
VKH
5
Virtu KCG Holdings
New York
| $56K | 26,259 | +26,259 | New |
|
|
WPC
6
White Pine Capital
Bloomington,
Minnesota
| $51K | 23,900 | +23,900 | New |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $34K | 15,605 | +15,605 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $17K | 8,117 | +6,115 | +305% |
|
9
UBS Group
Zurich,
Switzerland
| $8K | 3,760 | +1,105 | +42% |
|
10
Citigroup
New York
| $3K | 1,325 | +825 | +165% |
|
11
Morgan Stanley
New York
| $0 | 6 | – | – |
|